Composition: Salbutamol Base 2.5 mg + Ipratropium Bromide Anhydrous 0.5 mg.
Indications: For the management of reversible bronchospasm associated with obstructive airway diseases in patients who require more than a single bronchodilator.
Packaging: Butalpium: Ampoule of 5 ml, 10 Ampoules/ Box. Solution for Inhalation.
